NCT04050020

Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function

The Effect of Platelet-rich Plasma(PRP) Injection Treatment on Erectile Function: a Double-blind, Placebo Controlled Randomized Clinical Trial

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Institute for the Study of Urological Diseases, Greece · Academic / Other
• Sex: Male
• Age: 40 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the present study is to investigate and compare the treatment efficacy of PRP injection vs placebo treatment in men with mild-moderate vasculogenic ED, as measured by IIEF.The secondary objective of the present clinical trial is to study the adverse events and safety of the PRP injection treatment in vasculogenic ED patients

Conditions

• Erectile Dysfunction Due to Arterial Insufficiency

Interventions

Type	Name	Description
BIOLOGICAL	Platelet-Rich Plasma (PRP)	All subjects of this group will receive 2 sessions of PRP penile injection with 30 +/- 3 day treatment interval, 10 ml of PRP will be injected at each session.
BIOLOGICAL	Normal saline injection	All subjects of this group will receive 2 sessions of normal saline penile injection with 30 +/- 3 day treatment interval for all subjects, 10 ml of normal saline will be injected at each session.

Timeline

• Start date: 2019-09-02
• Primary completion: 2020-03-26
• Completion: 2020-09-24
• First posted: 2019-08-08
• Last updated: 2020-10-20

Locations

1 site across 1 country: Greece